APA (7th ed.) Citation

Shaaban, S. G., Chen, H., Singla, N., Tran, A., Hu, C., Ke, S., . . . Deville, C. (2025). Prospective phase II study of stereotactic body proton therapy for treatment of primary renal cell carcinoma (SPARE): Clinical trial protocol. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14486-1

Chicago Style (17th ed.) Citation

Shaaban, Sherif G., Hao Chen, Nirmish Singla, Anh Tran, Chen Hu, Suqi Ke, Thomas W. Jarrett, and Curtiland Deville. "Prospective Phase II Study of Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma (SPARE): Clinical Trial Protocol." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14486-1.

MLA (9th ed.) Citation

Shaaban, Sherif G., et al. "Prospective Phase II Study of Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma (SPARE): Clinical Trial Protocol." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14486-1.